Intriguingly, Li et al. [26] reported the upregulation of S100A16 and its family members in pancreatic ductal adenocarcinoma (PDAC) tissues compared to normal tissues, a phenomenon inversely related to promoter methylation. The gene discussed is S100A16; the disease is pancreatic ductal adenocarcinoma.